Brokers Offer Predictions for VRCA Q1 Earnings
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA – Free Report) – Research analysts at Brookline Capital Management issued their Q1 2025 earnings estimates for Verrica Pharmaceuticals in a report issued on Tuesday, March 11th. Brookline Capital Management analyst K. Dolliver expects that the company will post earnings per share of ($0.10) for the quarter. The consensus estimate for […]
